Breaking News Instant updates and real-time market news.

MAR

Marriott

$145.24

4.63 (3.29%)

10:31
02/15/18
02/15
10:31
02/15/18
10:31

Marriott says could return roughly $2.5B to shareholders in 2018

Expects to grow worldwide rooms by 7% gross, 5.5%-6% net in 2018. Expects to further reduce charge-out rates as company harmonizes loyalty program terms. Expects to introduce new credit cards in 2018. Says hotel owners can expect more cost savings in 2018. Sees North America RevPar up 1%-2% for FY18. Expects mid-single digit RevPar growth in Asia Pacific, low-single digit growth in Caribbean & Latin America, mid-single digit growth in Europe. Sees RevPar flat in Middle East & Africa and growth of 3%-5% for international. Says bullish about future. Sees mid-single digit RevPar growth for Asia Pacific, Caribbean & Latin America and Europe segments for Q1. Sees RevPar flat for Middle East & Africa in Q1. Sees International RevPar up 3%-5%, global RevPar up 1%-3% in Q1. Sees FY18 revenue $3.535B-$3.62B, EPS $5.11-$5.34, adjusted EBITDA $3.315B-$3.42B under new revenue standard. Says outlook excludes P&L impact of Avendra spending, merger-related costs, and timing of centralized programs and services. Says outlook assumes no further asset sales. Says could return roughly $2.5B to shareholders in 2018. Comments taken from Q4 earnings conference call.

  • 15

    Feb

  • 25

    Mar

MAR Marriott
$145.24

4.63 (3.29%)

01/29/18
RBCM
01/29/18
NO CHANGE
Target $159
RBCM
Outperform
Marriott price target raised to $159 from $111 at RBC Capital
RBC Capital Analyst West Golladay raised his price target on Marriott to $159 and kept his Outperform rating. The analyst cites the benefits from the U.S. tax reform adding to the prospects for improved domestic RevPAR growth as well as favorable FX adding to the positive trends of "strong unit growth, higher credit card fees, and healthy international RevPAR growth".
01/17/18
MSCO
01/17/18
DOWNGRADE
Target $84
MSCO
Equal Weight
Hilton downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Thomas Allen downgraded Hilton (HLT) to Equal Weight from Overweight despite raising his price target to $84 from $81, saying he sees fewer "idiosyncratic bull case drivers" for it versus Marriott (MAR) and La Quinta (LQ). He also said he is concerned around HNA's 25% Hilton stake, which could become a greater overhang if HNA begins unwinding other investments.
01/03/18
DBAB
01/03/18
NO CHANGE
Target $90
DBAB
Buy
Deutsche neutral on Lodging space into 2018, continues to favor Hilton
Deutsche Bank analyst Carlo Santarelli attributes the 2017 rally in Lodging stocks to a combination of favorable sector rotation, optimism around tax reform, new branded credit card deals and an acceleration in the return of capital. With the cycle one year closer to a natural conclusion and tax reform is complete, the analyst believes sector rotation is more likely to be a headwind than a tailwind in 2018. As such, he's taking a neutral approach to the group heading into 2018, while continuing to favor Hilton (HLT). Santarelli raised his price target for the Hilton to $90 from $79, for Choice Hotels (CHH) to $80 from $74, for Hyatt (H) to $78 from $72 and for Marriott (MAR) to $136 from $124.
12/21/17
RHCO
12/21/17
UPGRADE
Target $32
RHCO
Buy
Park Hotels & Resorts upgraded to Buy with $32 target at SunTrust
As previously reported, SunTrust analyst C. Patrick Scholes upgraded Park Hotels & Resorts (PK) to Buy from Hold, stating that stability now being seen in the Group business decreases his fear of downward earnings cuts and provides confidence that his estimates will hold. Stating that he expects Hilton (HLT) and Marriott (MAR) to hit the high-end of their Q4 RevPAR guidances, or beat them, Scholes said such a scenario would bode well for the hotel REITS like Park to do the same. He raised his price target on Park Hotels shares to $32 from $28.

TODAY'S FREE FLY STORIES

INTC

Intel

$53.20

(0.00%)

, AMD

AMD

$26.43

(0.00%)

09:40
03/25/19
03/25
09:40
03/25/19
09:40
Recommendations
Intel, AMD analyst commentary  »

CPU channel sell through…

INTC

Intel

$53.20

(0.00%)

AMD

AMD

$26.43

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Apr

VIAB

Viacom

$25.27

(0.00%)

, IYR

DJ US Real Estate Index Fund

$85.88

(0.00%)

09:40
03/25/19
03/25
09:40
03/25/19
09:40
Options
Unusually active option classes on open March 25th »

Unusual total active…

VIAB

Viacom

$25.27

(0.00%)

IYR

DJ US Real Estate Index Fund

$85.88

(0.00%)

NOK

Nokia

$5.94

(0.00%)

XLV

Health Care Select Sector SPDR

$90.70

(0.00%)

SQQQ

ProShares UltraPro Short QQQ

$10.36

(0.00%)

CRON

Cronos Group

$19.45

(0.00%)

XLU

Utilities SPDR

$58.60

(0.00%)

AAPL

Apple

$191.11

(0.00%)

JPM

JPMorgan

$99.78

(0.00%)

EWZ

MSCI Brazil Index

$40.34

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 12

    Apr

  • 20

    May

ADI

Analog Devices

$107.34

-2.79 (-2.53%)

09:38
03/25/19
03/25
09:38
03/25/19
09:38
Downgrade
Analog Devices rating change  »

Analog Devices downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Apr

  • 28

    May

TLND

Talend

$49.40

-1.81 (-3.53%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHI

Robert Half

$63.78

-2.58 (-3.89%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Hot Stocks
Breaking Hot Stocks news story on Robert Half »

Robert Half mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

09:35
03/25/19
03/25
09:35
03/25/19
09:35
Downgrade
Texas Instruments rating change  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Downgrade
Texas Instruments rating change  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
Lantheus promotes John Bolla to COO »

Lantheus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MEOH

Methanex

$57.73

-2.64 (-4.37%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
M&G Investments announces four director nominees for Methanex board »

M&G Investments, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$41.28

0.75 (1.85%)

09:32
03/25/19
03/25
09:32
03/25/19
09:32
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton benefiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:31
03/25/19
03/25
09:31
03/25/19
09:31
Hot Stocks
Lantheus announces upcoming retirement of Chief Medical Officer in September »

Lantheus Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NEON

Neonode

$2.80

(0.00%)

09:28
03/25/19
03/25
09:28
03/25/19
09:28
Hot Stocks
Neonode says Convergence Promotions to act as sales and marketing partner »

Neonode announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLXP

PLx Pharma

$5.54

-0.525 (-8.66%)

09:27
03/25/19
03/25
09:27
03/25/19
09:27
Syndicate
Breaking Syndicate news story on PLx Pharma »

PLx Pharma files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$184.59

-6.555 (-3.43%)

09:26
03/25/19
03/25
09:26
03/25/19
09:26
Hot Stocks
Wex to acquire fuel card business of EG Group »

WEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IART

Integra LifeSciences

$55.29

-2.07 (-3.61%)

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Conference/Events
Integra LifeSciences participates in a conference call with JPMorgan »

Medical Supplies &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

PTI

Proteostasis

$4.17

-0.14 (-3.25%)

, VRTX

Vertex

$181.49

-1.07 (-0.59%)

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Recommendations
Proteostasis, Vertex analyst commentary  »

Piper sees 'clear…

PTI

Proteostasis

$4.17

-0.14 (-3.25%)

VRTX

Vertex

$181.49

-1.07 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 10

    Apr

09:25
03/25/19
03/25
09:25
03/25/19
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

09:25
03/25/19
03/25
09:25
03/25/19
09:25
General news
A Spring Rebound for Producer Sentiment »

A Spring Rebound for…

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a meeting »

Open Commission Meeting…

ORGS

Orgenesis

$5.01

-0.19 (-3.65%)

09:24
03/25/19
03/25
09:24
03/25/19
09:24
Hot Stocks
Orgenesis to establish new facility for cell, gene therapy manufacturing »

Orgenesis announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$3.06

0.28 (10.07%)

09:24
03/25/19
03/25
09:24
03/25/19
09:24
Recommendations
Avon Products analyst commentary at DA Davidson »

Avon Products buyout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSL

MidSouth Bancorp

$10.22

-0.49 (-4.58%)

09:23
03/25/19
03/25
09:23
03/25/19
09:23
Upgrade
MidSouth Bancorp rating change  »

Sandler O'Neill says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:21
03/25/19
03/25
09:21
03/25/19
09:21
Conference/Events
JPMorgan retail analyst to hold an analyst/industry conference call »

Broadlines &…

PLAN

Anaplan

$38.98

-1.47 (-3.63%)

09:21
03/25/19
03/25
09:21
03/25/19
09:21
Initiation
Anaplan initiated  »

Anaplan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDOR

Condor Hospitality Trust

$8.70

(0.00%)

09:19
03/25/19
03/25
09:19
03/25/19
09:19
Hot Stocks
Condor Hospitality Trust announces sale of non-core legacy hotel »

Condor Hospitality Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.